Aspire-Lakewood Holdings, Inc. (ASBP) stock
ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
$7.89−0.41 (-4.94%)
Close on Nov 18, 2026Market cap $11.07MP/E –Yield –
Aspire-Lakewood operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Aspire-Lakewood's operating income for the twelve months ending Jun 30, 2026 was -$7.32M. For fiscal 2025 it was -$19.35M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.35M | – |
| FY2024 | Dec 31, 2024 | -$1.21M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.65M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.85M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.15M | – |
| Q2 FY2025 | Jun 30, 2025 | -$799.89K | – |
| Q1 FY2025 | Mar 31, 2025 | -$15.56M | – |
| Q4 FY2024 | Dec 31, 2024 | -$667.72K | – |
| Q3 FY2024 | Sep 30, 2024 | -$215.26K | – |
See a number that looks wrong?